|
Drug Discovery in the 21st Century
Discoveries in Development
Anti-Inflammatory Drugs
New Partnerships and New Technologies
Finding New Antibiotics for Drug-Resistant Fungi
Sustainable Use of our Marine Resources
Topically Administered Anti-Inflammatory Drugs
Anti-Inflammatory Drugs
Drugs to treat inflammation and pain in humans and animals are in constant demand.
Though some such drugs already exist, there are many conditions for which a more potent
treatment is desirable.
Collaborating together, researchers at Harbor Branch Oceanographic Institution and University of
California have isolated and characterized a class of bis(indole) alkaloid compounds with potent
anti-inflammatory properties. Topical administration of the compounds in mice effectively inhibits
both the immunogenic inflammatory effects of phorbol myristate acetate, and the neurogenic
inflammatory effects of resiniferatoxin and capsaicin.
The compounds may be useful for treatment of inflammation and pain, in such conditions as
rheumatoid arthritis, osteoarthritis, anaphylactic reactions, inflammatory bowel disease,
nephritis, conjunctivitis, inflammatory gum disease, migraine, metastic carcinoma, blood vessel
inflammation, acute asthmatic attack, and inflammation of the lung due to chemical exposure.
They may be useful for providing effective treatment for chemical, radiation or thermal burns
and may promote wound healing.
The advantages are that he compounds block the immunogenic inflammatory response to phorbol myristate acetate
more effectively than other known anti-inflammatory agents such as hydrocortisone, indomethacin
and manoalide, the compounds block the neurogenic inflammatory response to resiniferatoxin and
that potent analogs can be synthesized easily and economically.
INQUIRIES TO: Susan Sennett, Technology Transfer Associate - sennett@hboi.edu
REFERENCE: University of California (Pharmaceutical version Ð HB/S&S-15, 19, 21, 23 series)
Home
Programs & Facilities
Missions
Patents
Staff Profiles
Contact DBMR
|